Teva Pharm Indus (TEVJF) Total Assets by Year
Teva Pharm Indus Ltd closed fiscal year 2025 with $40.7B in total assets, $32.8B in total liabilities and $7.9B in shareholder equity. Total assets rose 3.6% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Teva Pharm Indus Ltd has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TEVJF Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $40.7B+3.6% | $39.3B-9.6% | $43.5B-1.2% | $44.0B-7.7% | $47.7B-5.9% | $50.6B-11.9% | $57.5B-5.3% | $60.7B-14.1% | $70.6B-24.1% | $93.1B+71.6% | $54.2B+16.8% | $46.4B-2.3% | $47.5B-6.1% | $50.6B+0.9% | $50.1B |
| Total Liabilities | $32.8B-2.3% | $33.6B-4.9% | $35.4B-0.2% | $35.4B-2.8% | $36.4B-8.0% | $39.6B-6.7% | $42.4B-5.5% | $44.9B-13.5% | $51.9B-10.7% | $58.1B+138.9% | $24.3B+5.4% | $23.1B-7.3% | $24.9B-10.3% | $27.7B-0.2% | $27.8B |
| Total Equity | $7.9B+47.2% | $5.4B-28.4% | $7.5B-3.8% | $7.8B-24.1% | $10.3B+2.5% | $10.0B-28.2% | $14.0B-5.0% | $14.7B-15.3% | $17.4B-47.9% | $33.3B+12.0% | $29.8B+27.7% | $23.3B+3.3% | $22.6B-0.9% | $22.8B+2.6% | $22.2B |
TEVJF Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $39.9B-0.7% | $40.0B+4.2% | $40.7B+3.6% | $39.9B-4.6% | $40.1B-2.9% | $38.4B-10.2% | $39.3B-9.6% | $41.8B-0.8% | $41.3B-4.1% | $42.8B-1.6% | $43.5B-1.2% | $42.1B-4.9% |
| Total Liabilities | $32.1B-3.6% | $31.8B-1.0% | $32.8B-2.3% | $32.6B-7.8% | $33.3B-4.2% | $32.1B-8.8% | $33.6B-4.9% | $35.4B+1.9% | $34.8B-2.1% | $35.2B+0.8% | $35.4B-0.2% | $34.7B-0.1% |
| Total Equity | $7.8B+13.6% | $8.2B+31.4% | $7.9B+47.2% | $7.3B+19.5% | $6.8B+7.4% | $6.3B-14.0% | $5.4B-28.4% | $6.1B-12.5% | $6.4B-9.8% | $7.3B-7.4% | $7.5B-3.8% | $6.9B-21.0% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Teva Pharm Indus Ltd financials
Frequently Asked Questions
Teva Pharm Indus Ltd closed fiscal year 2025 with $40.7B in total assets, $32.8B in total liabilities and $7.9B in shareholder equity.
Teva Pharm Indus Ltd (TEVJF) total assets rose by 3.6% year over year, from $39.3B to $40.7B in fiscal year 2025.
Across the 15 fiscal years this page covers, Teva Pharm Indus Ltd (TEVJF) total assets went from $50.1B in fiscal year 2011 to $40.7B in fiscal year 2025.
Teva Pharm Indus Ltd (TEVJF) reported $39.9B in total assets in Q2 2026. This represents a decrease of 0.7% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Teva Pharm Indus Ltd (TEVJF) reported on that line in every period on record.